BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23024112)

  • 1. Intensity modulated radiation therapy provides excellent local control in high-risk abdominal neuroblastoma.
    Pai Panandiker AS; Beltran C; Billups CA; McGregor LM; Furman WL; Davidoff AM
    Pediatr Blood Cancer; 2013 May; 60(5):761-5. PubMed ID: 23024112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton radiotherapy for high-risk pediatric neuroblastoma: early outcomes and dose comparison.
    Hattangadi JA; Rombi B; Yock TI; Broussard G; Friedmann AM; Huang M; Chen YL; Lu HM; Kooy H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1015-22. PubMed ID: 22138463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity.
    Paulino AC; Mayr NA; Simon JH; Buatti JM
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1025-31. PubMed ID: 11958898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent local control from radiation therapy for high-risk neuroblastoma.
    Gatcombe HG; Marcus RB; Katzenstein HM; Tighiouart M; Esiashvili N
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1549-54. PubMed ID: 19211198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term side effects of radiotherapy for pediatric localized neuroblastoma : results from clinical trials NB90 and NB94.
    Ducassou A; Gambart M; Munzer C; Padovani L; Carrie C; Haas-Kogan D; Bernier-Chastagner V; Demoor C; Claude L; Helfre S; Bolle S; Leseur J; Huchet A; Rubie H; Valteau-Couanet D; Schleiermacher G; Coze C; Defachelles AS; Marabelle A; Ducassou S; Devalck C; Gandemer V; Munzer M; Laprie A;
    Strahlenther Onkol; 2015 Jul; 191(7):604-12. PubMed ID: 25896312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
    Bagatell R; Rumcheva P; London WB; Cohn SL; Look AT; Brodeur GM; Frantz C; Joshi V; Thorner P; Rao PV; Castleberry R; Bowman LC
    J Clin Oncol; 2005 Dec; 23(34):8819-27. PubMed ID: 16314642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1.
    Rubie H; De Bernardi B; Gerrard M; Canete A; Ladenstein R; Couturier J; Ambros P; Munzer C; Pearson AD; Garaventa A; Brock P; Castel V; Valteau-Couanet D; Holmes K; Di Cataldo A; Brichard B; Mosseri V; Marquez C; Plantaz D; Boni L; Michon J
    J Clin Oncol; 2011 Feb; 29(4):449-55. PubMed ID: 21172879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of conventional to intensity modulated radiation therapy for abdominal neuroblastoma.
    Paulino AC; Ferenci MS; Chiang KY; Nowlan AW; Marcus RB
    Pediatr Blood Cancer; 2006 Jun; 46(7):739-44. PubMed ID: 16302219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience in pediatric neuroblastoma intensity modulated radiotherapy.
    Nazmy MS; Khafaga Y
    J Egypt Natl Canc Inst; 2012 Dec; 24(4):185-9. PubMed ID: 23159289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma.
    Paulino AC; Mazloom A; Terashima K; Su J; Adesina AM; Okcu MF; Teh BS; Chintagumpala M
    Cancer; 2013 Jul; 119(14):2654-9. PubMed ID: 23633429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.
    Pinnix CC; Fontanilla HP; Hayes-Jordan A; Subbiah V; Bilton SD; Chang EL; Grosshans DR; McAleer MF; Sulman EP; Woo SY; Anderson P; Green HL; Mahajan A
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):317-26. PubMed ID: 22104361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
    Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-volume analysis of locoregional recurrences in head and neck IMRT, as determined by deformable registration: a prospective multi-institutional trial.
    Shakam A; Scrimger R; Liu D; Mohamed M; Parliament M; Field GC; El-Gayed A; Cadman P; Jha N; Warkentin H; Skarsgard D; Zhu Q; Ghosh S
    Radiother Oncol; 2011 May; 99(2):101-7. PubMed ID: 21621868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity-modulated radiotherapy with use of cone-down boost for pediatric head-and-neck rhabdomyosarcoma.
    McDonald MW; Esiashvili N; George BA; Katzenstein HM; Olson TA; Rapkin LB; Marcus RB
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):884-91. PubMed ID: 18455321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of palliative radiotherapy in the management of metastatic pediatric neuroblastoma: a retrospective single-institution study.
    Caussa L; Hijal T; Michon J; Helfre S
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):214-9. PubMed ID: 20382484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiation therapy with dose-painting for pediatric sarcomas with pulmonary metastases.
    Yang JC; Wexler LH; Meyers PA; Happersett L; La Quaglia MP; Wolden SL
    Pediatr Blood Cancer; 2013 Oct; 60(10):1616-20. PubMed ID: 23765910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.
    Bradfield SM; Douglas JG; Hawkins DS; Sanders JE; Park JR
    Cancer; 2004 Mar; 100(6):1268-75. PubMed ID: 15022296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.